About the Journal


Perspective in Oncology Management and Research is a prestigious international, peer - reviewed, open - access journal dedicated to oncology. Our core mission is to offer a top - tier platform for scientists, clinicians, and researchers to share their state - of - the - art experimental and theoretical findings. We emphasize transparency and reproducibility, urging authors to provide full experimental details for others to replicate and expand on their work.

 

Molecular and Genomic Oncology

  • Pathway analyses and signaling networks in tumor initiation and progression
  • Role of non-coding RNAs (e.g., miRNAs, lncRNAs) in cancer biology and therapy
  • Epigenetic mechanisms (DNA methylation, histone modification) in carcinogenesis and treatment resistance
  • Cancer genetics, including hereditary cancer syndromes and germline mutations

Liquid Biopsy and Early Detection

  • Circulating tumor cells (CTCs), cell-free DNA (cfDNA), and exosomes as biomarkers for early diagnosis, prognosis, and monitoring
  • Advances in liquid biopsy technologies for minimal residual disease detection and treatment response assessment

Tumor Heterogeneity and Cancer Stem Cells

  • Molecular characterization of cancer stem cells and their role in metastasis, recurrence, and therapy resistance
  • Strategies targeting tumor-initiating cells to improve treatment outcomes

Tumor Immunology and Immunotherapy

  • Immune checkpoint inhibitors, CAR-T cell therapies, and cancer vaccines
  • Mechanisms of immune evasion and strategies to overcome resistance
  • Interactions between the tumor microenvironment and immune cells

Tumor Microenvironment and Metastasis

  • Role of stromal cells, extracellular matrix, and metabolic reprogramming in tumor progression
  • Angiogenesis, hypoxia, and inflammation in cancer development

Targeted Therapies and Precision Oncology

  • Novel small-molecule inhibitors, monoclonal antibodies, and combination therapies
  • Overcoming drug resistance through rational drug design and repurposing strategies

Clinical Oncology and Translational Research

  • Phase I-III clinical trials evaluating new therapeutic agents or regimens
  • Real-world evidence studies on treatment patterns, outcomes, and health economics
  • Cancer risk screening, prevention, and survivorship care

Interdisciplinary and Emerging Fields

  • Nanotechnology, AI, and machine learning in cancer diagnosis and treatment optimization
  • Studies integrating basic, clinical, and population-level data to improve cancer care